Join Class Action »
Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Vaxart, Inc. (NASDAQ: VXRT) from June 25, 2020 through July 25, 2020 (the “Class Period”). The lawsuit seeks to recover damages for Vaxart, Inc. investors under the federal securities laws.
If you bought Vaxart, Inc. securities between June 25, 2020 through July 25, 2020, and would like to join the action, please click “Join This Class Action,” above.
SHAREHOLDER ALERT: Zhang Investor Law Announces a Securities Class Action Lawsuit Against Vaxart, Inc. – VXRT
New York, N.Y., September 16, 2020. Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Vaxart, Inc. (NASDAQ: VXRT) between June 25, 2020 and July 25, 2020, inclusive (the “Class Period”).
To join the VXRT class action, go to http://zhanginvestorlaw.com/cases/vaxart-inc/ call Sophie Zhang, Esq. toll-free at 800-991-3756 or email firstname.lastname@example.org for information on the class action.
Lead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time.
According to the lawsuit, throughout the Class Period Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed (“OWS”). Contrary to defendants’ statements, Vaxart’s COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies selected to receive significant financial support from OWS to produce hundreds of millions of vaccine doses. Instead, Vaxart’s COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 23, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://zhanginvestorlaw.com/cases/vaxart-inc/ or to discuss your rights or interests regarding this class action, please contact Sophie Zhang, Esq. of Zhang Investor Law toll free at 800-991-3756 or via e-mail at email@example.com.
Zhang Investor Law represents investors worldwide.